Designating October 13, 2026, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania.
Senate Resolution 256 designates October 13, 2026, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania. The resolution is largely commemorative and declaratory: it recognizes metastatic breast cancer as an incurable stage of breast cancer, highlights the number of people affected in Pennsylvania and nationwide, and emphasizes the need for research, awareness, and equitable access to care.
The resolution includes findings about the severity of metastatic breast cancer, the proportion of breast cancers that eventually metastasize, the mortality associated with the disease, and disparities in outcomes by race and ethnicity. It also references the METAvivor Research and Support organization and the global #LightUpMBC campaign, which illuminate landmarks in teal, green, and pink to raise awareness and honor patients and families affected by the disease.
SR256 does not create or amend statutory law, regulate conduct, or appropriate funds. Its legal effect is to establish an official awareness day in Pennsylvania and to encourage public recognition of metastatic breast cancer, with indirect policy implications by drawing attention to research funding, patient support, and equitable access to treatment. The resolution primarily affects state government observances, public awareness efforts, advocacy organizations, and Pennsylvanians living with metastatic breast cancer and their families.
The bill appears to have broad supportive sentiment based on its bipartisan sponsorship and the absence of recorded opposition, votes, or committee controversy in the provided materials. The tone of the resolution is sympathetic and advocacy-oriented, framing the observance as a way to honor patients, survivors, and those lost to the disease while promoting hope and research. Overall, the measure is presented as a consensus recognition of a serious public health issue.
No formal points of contention are shown in the available record, and there are no committee transcripts or votes indicating disagreement. The resolution does, however, implicitly highlights policy concerns that could be debated outside the resolution itself, including the adequacy of metastatic breast cancer research funding, persistent racial and ethnic disparities in outcomes, and the need for equitable access to care across urban, suburban, and rural communities. Those issues are raised as reasons for the observance rather than as disputed provisions of the resolution.